CUSTOMER SUPPORT CUSTOMER SUPPORT +91-9999-696-045

fund search

Individually analyse each scheme and narrow your options further Every minute detail you need to know about scheme of your choice from asset holdings, best and worst performance and fund returns to competitor analysis; is available in the Fund card.
Using this report card, you can gather vital information regarding the future health of the scheme by analysing the top 10 companies and sectors it invests in. You can also track the fund management’s track record and analyse the philosophy behind scheme’s holdings. All the parameters in the fund card are extremely important and can go a long way in helping you decide which scheme to invest your money.

NAV As on Jun-01-2020

DSP Healthcare Fund(G)-Direct Plan

Top 10 Holdings
Company
(%)
IPCA Laboratories Limited
10.09
Dr. Reddy's Laboratories Limited
9.62
JB Chemicals & Pharmaceuticals Limited
8.36
Divi's Laboratories Limited
7.45
TREPS / Reverse Repo Investments / Corporate Debt Repo
7.25
Indoco Remedies Limited
4.71
Sun Pharmaceutical Industries Limited
4.30
Torrent Pharmaceuticals Limited
3.79
Procter & Gamble Health Limited
3.72
Alembic Pharmaceuticals Limited
3.69
Top 10 Sectors
Sectors
(%)
Pharmaceuticals & Drugs
69.90
Hospital & Healthcare Services
7.46
Chemicals
3.31
Miscellaneous
2.48
Insurance
2.27
Finance - Investment
2.25
Asset Allocation
Market Cap Allocation
  Scheme Benchmark (S&P BSE Health Care)
Large-Cap 34.38 55.43
Mid-Cap 30.68 32.18
Small-Cap 34.94 13.57

Best and Worst Performance and Ratios

Best Performance in a year
Period Fund (%) Benchmark (%)
Year 31/05/19
to 01/06/20
34.1118.08
Worst Performance in a year
Period Fund (%) Benchmark (%)
Year 22/03/19
to 23/03/20
-3.97-22.39
Ratios
Standard Deviation[%] 25.49
Sharpe Ratio [%] 0.45
Turnover Ratio [%] 0.12
Modified Duration
YTM
Riskometer
high risk

Investors understand that their principal will be at high risk

Fund Details
Category
Sector Funds
Inception Date (Regular Plan)
30-Nov-18
Inception Date (Direct Plan)
30-Nov-18
Expense Ratio (Direct Plan) %
0.97
Expense Ratio (Regular Plan) %
2.46
Investing Style
Small Growth
Fund Manager
Aditya Khemka,Vinit Sambre,Jay Kothari
Scheme Benchmark
S&P BSE HEALTH CARE
AUM (Rs. in Cr.)
371.98
Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

Growth Chart of the Scheme Versus Benchmark (SIP value Rs10,000)
DSP Healthcare Fund(G)-Direct Plan S&P BSE Health Care

Performance Comparison with similar Schemes and Benchmark